Julphar strikes deal to supply disposable insulin pens in UAE

RAS AL KHAIMAH / WAM

Julphar has signed an agreement with leading global medical technology company BD (Becton, Dickinson and Company) to supply disposable insulin pens in the UAE.
BD develops innovative technologies, services and solutions that help advance both the clinical process for healthcare providers and clinical therapy for patients, including a wide variety of insulin delivery devices for diabetics.
Jerome Carle, GM of Julphar, said, “The global diabetes market is large and growing. Through our agreement with BD, we will be able to keep pace with the growth and further improve our position in this lucrative market, placing us among the top three players in the world.”